It has proved especially valuable for speech recognition and for classification (see “10 Breakthrough Technologies 2013: Deep Learning”). Genome machine learning company Deep Genomics is using artificial intelligence to develop drugs to tackle diseases related to gene defects . The company analyses genomic data using algorithms to identify the genes intrinsic to particular illnesses , making it an ideal for developing highly - targeted drugs . Deep Gen will first focus on early stage drug development for Mendelian disorders , which are caused by a specific genetic mutation which affects around 350 million people globally .
Genome machine learning company Deep Genomics is using artificial intelligence to develop drugs to tackle diseases related to gene defects . The company analyses genomic data using algorithms to identify the genes intrinsic to particular illnesses , making it an ideal for developing highly - targeted drugs . Deep Gen will first focus on early stage drug development for Mendelian disorders , which are caused by a specific genetic mutation which affects around 350 million people globally .